Feasibility of minimal residual disease studies by multiparametric flow cytometry for acute myeloid leukemia in a developing country

Author(s):Show less -

de Figueiredo-Pontes, Lorena Lobo ^{[1, 2]} ; Ayrosa Madeira, Maria Isabel ^{[1, 2]} ; Correa de Araujo, Luisa Koury ^{[1, 2]} ; Scheucher, Priscila Santos ^{[1, 2]} ; Traina, Fabiola ^{[1, 2]} ; Gouvea de Lima, Ana Silvia ^{[1, 2]} ; Pagnano, Katia ^[3] ; Pallota, Ronald ^[4] ; Bittencourt, Rosane ^[5] ; Chauffaille, Maria de Lourdes ^[6] ; Pedron Oltramari, Marcos Roberto ^[7] ; Higashi, Marcia ^[8] ; Bendlin, Rodrigo Miguel ^[9] ; Coustan-Smith, Elaine ^[10] ; Campana, Dario ^[10] ; Rego, Eduardo Magalhaes ^{[1, 2]}

Affiliation

^[1] Med Sch Ribeirao Preto, Dept Med, Div Hematol, Ribeirao Preto, SP - Brazil

^[2] Univ Sao Paulo, Ctr Cell Based Therapy, Ribeirao Preto, SP - Brazil

^[3] Univ Estadual Campinas, Hemocentro, Campinas, SP - Brazil

^[4] ABC Med Sch, Sao Paulo - Brazil

^[5] Fed Univ Rio Grande, Univ Hosp, Hematol Div, Porto Alegre, RS - Brazil

^[6] Univ Fed Sao Paulo, Hematol Div, Sao Paulo - Brazil

^[7] Hosp Base, Bone Marrow Transplant Ctr, Sao Jos Rio Preto, Sao Jose Do Rio Preto - Brazil

^[8] Amaral Carvalho Hosp, Jau - Brazil

^[9] Univ Fed Parana, Univ Hosp, Hematol Div, Curitiba, Parana - Brazil

^[10] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pediat, Singapore - Singapore

• Document type: Journal article
• Source: BLOOD ADVANCES; v. 1, n. 1, p. 80-83, DEC 8 2017.
• Web of Science Citations: 0

Abstract

• FAPESP's process: 13/08135-2 - CTC - Center for Cell-Based Therapy
• Grantee: Dimas Tadeu Covas
• Support type: Research Grants - Research, Innovation and Dissemination Centers - RIDC